Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(3)
ODS 3: Salud y bienestar(3)
ODS 17: Alianzas para lograr los objetivos(1)
ODS 5: Igualdad de género(1)
ODS 9: Industria, innovación e infraestructura(1)
Origen
scopus(3)
Alterations of immunological parameters in an autochthonous case of visceral leishmaniasis from the northwest of Argentina
ArticleAbstract: We report the alterations of immunological parameters of a patient with visceral leishmaniasis causePalabras claves:B-lymphocyte differentiation, cytokines, T-lymphocyte differentiation, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., de Bracco M.M.d.E., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.Fuentes:scopusDevelopment of a Fluorescent Assay to Search New Drugs Using Stable tdTomato-Leishmania, and the Selection of Galangin as a Candidate With Anti-Leishmanial Activity
ArticleAbstract: Antimonials continue to be considered the first-line treatment for leishmaniases, but its use entailPalabras claves:flavonoids, Fluorescence, galangin, L. (L.) amazonensis, tdTomatoAutores:Buttazzoni Zuñiga V.C., Jorge Diego Marco, Manghera P., María Fernanda García Bustos, Moya Álvarez A., Paola Andrea Barroso, Parodi C.M., Pastrana O.M., Peñalva P.A., Pérez Brandán C., Sosa A.M.Fuentes:scopusMiltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis
ArticleAbstract: The conventional treatment for tegumentary leishmaniasis is meglumine antimoniate, which needs parenPalabras claves:Leishmaniasis treatment, Miltefosine, Mucocutaneous leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., María Fernanda García Bustos, Moreno S., Parodi C.M.Fuentes:scopus